PedsEndoPhilly said:It helps to ask what evidence would change your mind before you look at any.
That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.
PharmHunterJen said:Right, and one flattering data point from a group buy is not consistency.
Thank you for spelling out the reasoning rather than just the conclusion. Adding it to my notes with a link back to this thread.
PedsEndoPhilly said:It helps to ask what evidence would change your mind before you look at any.
This is where I part company with the consensus forming above. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsThe figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.